Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
RNAi screen for vemurafenib enhancer genes in BRAFV600 melanoma - Primary Screen
Assay data:790 Active, 18119 Tested
Summary
Binding affinity to N-terminal His-tagged full length human PSD-95alpha PDZ2 domain (155 to 249 residues) without exon 4b expressed in Escherichia coli BL21(DE3)pLysS by isothermal titration colorimetric method
Assay data:2 Tested
SummaryRelated BioAssays by Target
Ratio of Kd for N-terminal His-tagged full length human PSD-95alpha PDZ2 domain (155 to 249 residues) without exon 4b expressed in Escherichia coli BL21(DE3)pLysS by isothermal titration colorimetric method to Ki for N-terminal His-tagged full length human PSD-95alpha PDZ2 domain (155 to 249 residues) without exon 4b expressed in Escherichia coli BL21(DE3)pLysS by fluorescence polarization assay
Displacement of Cy5-CRIPT from N-terminal His-tagged human full length PSD-95alpha PDZ3 domain (309 to 401 residues) without exon 4b expressed in Escherichia coli BL21(DE3)pLysS by fluorescence polarization assay
Assay data:3 Tested
Displacement of Cy5-GluN2B from N-terminal His-tagged full length human PSD-95alpha PDZ2 domain (155 to 249 residues) without exon 4b expressed in Escherichia coli BL21(DE3)pLysS by fluorescence polarization assay
Assay data:7 Tested
Displacement of Cy5-GluN2B from N-terminal His-tagged human full length PSD-95alpha PDZ1 domain (61 to 151 residues) without exon 4b expressed in Escherichia coli BL21(DE3)pLysS by fluorescence polarization assay
Assay data:5 Tested
Potency index, ratio of indole 1 Ki to compound Ki for N-terminal His-tagged full length human PSD-95alpha PDZ2 domain (155 to 249 residues) without exon 4b expressed in Escherichia coli BL21(DE3)pLysS
Assay data:1 Tested
Primary screen of kinases in signalling pathway between Protease activated receptor 2 (PAR2) and the ion channels Transient receptor potential vanilloid-4 (TRPV4) in HEK293 cells
Assay data:91 Active, 714 Tested
A screen to identify synergistic combinations in colorectal cancer - Primary Screen (SW620)
Assay data:15 Active, 794 Tested
SummaryPubMed CitationRelated BioAssays by Depositor
A screen to identify synergistic combinations in colorectal cancer - Primary Screen (SNUC5)
Assay data:11 Active, 794 Tested
A screen to identify synergistic combinations in colorectal cancer - Primary Screen (HCT15)
Assay data:18 Active, 794 Tested
A screen to identify synergistic combinations in colorectal cancer - Primary Screen (CAR1)
Assay data:9 Active, 794 Tested
A screen to identify synergistic combinations in colorectal cancer - Primary Screen (HT55)
Assay data:20 Active, 794 Tested
A screen to identify synergistic combinations in colorectal cancer - Primary Screen (RCM1)
Assay data:13 Active, 794 Tested
A screen to identify synergistic combinations in colorectal cancer - Primary Screen (HT29)
A screen to identify synergistic combinations in colorectal cancer - Primary Screen (SNUC1)
A screen to identify synergistic combinations in colorectal cancer - Primary Screen (LS513)
Assay data:16 Active, 794 Tested
A screen to identify synergistic combinations in colorectal cancer - Primary Screen (NCIH630)
Assay data:17 Active, 794 Tested
A screen to identify synergistic combinations in colorectal cancer - Primary Screen (HCC56)
A screen to identify synergistic combinations in colorectal cancer - Primary Screen (SW48)
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on